Patient Preparation

  • Same for PET and SPECT
  • Fast for ≥6 hrs (except water intake)
  • Avoid caffeine for ≥12 hours
  • Avoid theophylline-containing medications for ≥ 48 hours

Vasodilators

  • Most commonly, vasodilators are used to ↑ blood flow to normally perfused areas of the myocardium, uncovering potential areas of decreased perfusion caused by fixed coronary stenoses.
  • All vasodilators act through the adenosine pathway leading to vascular smooth muscle vasorelaxation.
  • Side effects with vasodilators 1
    • Vasodilators are safe in patients with a history of COPD or asthma, but do not give vasodilators in a patient with a recent exacerbation or active wheezing.
  • Indications for reversal of vasodilators (although most side effects are self-limiting)
    • Indications for reversal include severe hypotension, 2nd- or 3rd-degree heart block, ST depression with angina, wheezing, or intolerable symptoms.
    • Adenosine almost never requires reversal due to the short half-life.
    • For mild symptoms, ask patient to consume coffee ☕️ or diet soda 🥤 after completing the test.
    • Reversal agents:
      • Aminophylline 50-250mg IV over 1 minute (do not give if having a seizure as this lowers the seizure threshold).
      • IV theophylline 50mg slow injection over 1 minute.
      • IV caffeine 60mg in 25mL of D5W over 3-5 minutes.
      • PO caffeine 60-160mg

Adenosine

  • See Adenosine
  • Adenosine directly activates the A2a receptor causing coronary vasodilation, but also activates other adenosine receptors.
  • Half-life is 2-10 seconds.
  • Off-target effects:
    • A1 receptor: AV block, chest pain and tachypnea
    • A2b receptor: peripheral vasodilation (headache, diarrhea)
    • A2b/A3 receptor: bronchospasm
  • Protocol: continuous infusion of 140 mcg/kg/min for 6 minutes, inject radiotracer at 3 minutes.
  • Contraindications: bronchospasm, hypotension, heart block.

Regadenoson (Lexiscan)

  • Regadenoson (Lexiscan): Directly activates A2a receptors with high affinity and low off-target effects causing coronary vasodilation.
    • -selective adenosine receptor agonist
  • Half-life for hyperemia is 3-5 minutes.
    • Peak-effect onset at ~1 min post bolus injection with a duration of approximately 8 to 10 minutes at ≥80% peak effect
    • Triphasic half-life so may have side effects of headache, chest pain, diarrhea for 15-20 minutes.
  • Off-target effects are less than with adenosine.
  • Protocol: rapid injection over 10 seconds followed by saline flush. Radionuclide is injected 10-20 seconds after saline.
  • Caution: seizures, LBBB, pacemaker.
  • Bradyarrhythmias with regadenoson are thought to be secondary to vagal stimulation via the A2a receptor in the hypothalamus and nucleus solitarius.
  • ADVANCE trial compared Regadenoson vs Adenosine
    • Run-in phase to ensure all participants tolerated adenosine
    • tl;dr: regadenoson provided similar Dx information compared to standard adenosine infusion. There were no serious AEs with regadenoson and regadenoson was better tolerated.

Dipyridamole (Persantine)

  • Dipyridamole (Persantine): Phosphodiesterase inhibitor that prevents intracellular reuptake of adenosine.
  • Half-life: Maximal hyperemia in 15 minutes. Alpha half-life is 30-60 minutes, beta half-life 10 hours.
  • Off-target effects: Similar potential to adenosine. May have late symptoms after aminophylline reversal agents have worn off.
  • Protocol: Infusion over 4 minutes, then inject radiotracer 3-5 min after dipyridamole infusion is complete.
  • Consider using preferentially if history of seizure, pacemaker, LBBB.

The rate of side effects for vasodilator agents are seen in the above table.

Contraindications to Vasodilators

  • Patients with significant reactive/bronchospastic lung disease with ongoing wheezing or recent exacerbation requiring steroids/significant escalation of medical therapy
  • Second degree Mobitz Type 2 or third-degree AV block without a functioning pacemaker
  • Severe symptomatic bradycardia without a functioning pacemaker
  • Profound sinus bradycardia (heart rates per 40/min)
  • Symptomatic aortic aneurysm
  • Recent (<48 hours) use of dipyridamole or dipyridamole-containing medications (for regadenoson and adenosine)
  • Ingestion of caffeinated foods or beverages within the last 12-24 hours
  • Seizure disorder active within the last 6 months
  • Junctional rhythm
  • Acute left ventricular thrombus, especially mobile, protruding, or pedunculated

Indications for reversal/termination of Vasodilators

  • Same are those mentioned for Exercise
  • Symptomatic hypotension (SBP <90 mmHg)
  • Wheezing
  • Development of persistent second degree or complete AV block
  • Other significant cardiac arrhythmia
  • Excessive STD (horizontal or downsloping) >2 mm from baseline
  • Severe or increasing chest pain of unclear etiology
  • Can be considered in the presence of less-severe side effects or ischemic ECG changes if at least 1 minute has elapsed since radiotracer injection

Dobutamine

  • Beta-adrenergic agonist:
  • Hemodynamic effects similar to exercise
  • Increases in coronary flow less than vasodilator stress
  • Protocol: administered incrementally beginning at a dose of 5-10 mcg/kg/min, which is increased at 3-minute intervals to 20, 30, and 40 mcg/kg/min.
    • Radiotracer is injected once ≥85% MPHR achieved with DBA infusion continuing for 1 minute after tracer injection.
    • Use a weight-based dose up to 250 lbs.
    • Dose increased incrementally to 40 mcg/min/kg
  • Atropine administered to increase HR if required
  • Use in pts unable to exercise with a contraindication to vasodilator stress
  • Side-effects: palpitations, CP, dyspnea, headache, arrhythmia, Bezold-Jarisch reflex

Contraindications to Dobutamine

Footnotes

  1. https://www.asnc.org/blog_home.asp?display=433